The story of Sildenafil presents a nuanced case for investors in the drug sector. While initially a blockbuster success, creating huge profits, the exclusivity expiration and the subsequent flood of generic https://knockoff974583.blogdemls.com/41520915/the-little-copyright-and-pharma-a-risky-investment